(Q67901608)

English

High affinity dopamine D2 receptor radioligands. 2. [125I]epidepride, a potent and specific radioligand for the characterization of striatal and extrastriatal dopamine D2 receptors

scientific article published on 01 January 1991

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1830917%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

High affinity dopamine D2 receptor radioligands. 2. [125I]epidepride, a potent and specific radioligand for the characterization of striatal and extrastriatal dopamine D2 receptors (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1830917%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

author name string

R. M. Kessler

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1830917

4 December 2022

M. S. Ansari

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1830917

4 December 2022

D. E. Schmidt

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1830917

4 December 2022

T. de Paulis

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1830917

4 December 2022

J. A. Clanton

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1830917

4 December 2022

R. Innis

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1830917

4 December 2022

M. al-Tikriti

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1830917

4 December 2022

R. G. Manning

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1830917

4 December 2022

D. Gillespie

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1830917

4 December 2022

language of work or name

0 references

publication date

1 January 1991

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1830917%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

number of pages

12

1 reference

based on heuristic

inferred from page(s)

full work available at URL

https://api.elsevier.com/content/article/PII:0024320591902619?httpAccept=text/xml

1 reference

10.1016/0024-3205(91)90261-9

https://api.crossref.org/works/10.1016/0024-3205(91)90261-9

4 December 2022

https://api.elsevier.com/content/article/PII:0024320591902619?httpAccept=text/plain

1 reference

10.1016/0024-3205(91)90261-9

https://api.crossref.org/works/10.1016/0024-3205(91)90261-9

4 December 2022

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1830917%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

49

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1830917%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1830917%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

617-628

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1830917%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

Beyond the dopamine hypothesis. The neurochemical pathology of schizophrenia.

3

1 reference

10.1016/0024-3205(91)90261-9

https://api.crossref.org/works/10.1016/0024-3205(91)90261-9

4 December 2022

Dopamine receptors in human brain: autoradiographic distribution of D2 sites

4

1 reference

10.1016/0024-3205(91)90261-9

https://api.crossref.org/works/10.1016/0024-3205(91)90261-9

4 December 2022

Widespread distribution of brain dopamine receptors evidenced with [125I]iodosulpride, a highly selective ligand

5

1 reference

10.1016/0024-3205(91)90261-9

https://api.crossref.org/works/10.1016/0024-3205(91)90261-9

4 December 2022

Chronic haloperidol administration increases the density of D2 dopamine receptors in the medial prefrontal cortex of the rat.

6

1 reference

10.1016/0024-3205(91)90261-9

https://api.crossref.org/works/10.1016/0024-3205(91)90261-9

4 December 2022

Dopamine D2 receptors in the rat brain: autoradiographic visualization using a high-affinity selective agonist ligand

7

1 reference

10.1016/0024-3205(91)90261-9

https://api.crossref.org/works/10.1016/0024-3205(91)90261-9

4 December 2022

Chronic morphine administration increases the apparent number of α2-adrenergic receptors in rat brain

9

1 reference

10.1016/0024-3205(91)90261-9

https://api.crossref.org/works/10.1016/0024-3205(91)90261-9

4 December 2022

Neurotransmitter receptor binding: regional distribution in human brain

10

1 reference

10.1016/0024-3205(91)90261-9

https://api.crossref.org/works/10.1016/0024-3205(91)90261-9

4 December 2022

PET measurement of D2 and S2 receptor binding of 3-N-[( 2'-18F]fluoroethyl)spiperone in baboon brain

11

1 reference

10.1016/0024-3205(91)90261-9

https://api.crossref.org/works/10.1016/0024-3205(91)90261-9

4 December 2022

Molecular Pharmacology

13

15

506

author name string

Howlett

publication date

1979

1 reference

10.1016/0024-3205(91)90261-9

https://api.crossref.org/works/10.1016/0024-3205(91)90261-9

4 December 2022

The substituted benzamides - a novel class of dopamine antagonists

14

1 reference

10.1016/0024-3205(91)90261-9

https://api.crossref.org/works/10.1016/0024-3205(91)90261-9

4 December 2022

Specific in vitro and in vivo binding of 3H-raclopride. A potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brain

15

1 reference

10.1016/0024-3205(91)90261-9

https://api.crossref.org/works/10.1016/0024-3205(91)90261-9

4 December 2022

In vitro binding properties and autoradiographic imaging of 3-iodobenzamide ([125I]-IBZM): a potential imaging ligand for D-2 dopamine receptors in SPECT.

17

1 reference

10.1016/0024-3205(91)90261-9

https://api.crossref.org/works/10.1016/0024-3205(91)90261-9

4 December 2022

Autoradiographic localization of [3H]sulpiride binding sites in the rat brain

18

1 reference

10.1016/0024-3205(91)90261-9

https://api.crossref.org/works/10.1016/0024-3205(91)90261-9

4 December 2022

Localization of dopamine D2 receptor mRNA and D1 and D2 receptor binding in the rat brain and pituitary: an in situ hybridization-receptor autoradiographic analysis

20

1 reference

10.1016/0024-3205(91)90261-9

https://api.crossref.org/works/10.1016/0024-3205(91)90261-9

4 December 2022

Some in vitro receptor binding properties of [3H]eticlopride, a novel substituted benzamide, selective for dopamine-D2 receptors in the rat brain

21

1 reference

10.1016/0024-3205(91)90261-9

https://api.crossref.org/works/10.1016/0024-3205(91)90261-9

4 December 2022

Regional in vivo binding of the substituted benzamide [3H]eticlopride in the rat brain: evidence for selective labelling of dopamine receptors

22

1 reference

10.1016/0024-3205(91)90261-9

https://api.crossref.org/works/10.1016/0024-3205(91)90261-9

4 December 2022

Dopamine D2 receptors selectively labeled by a benzamide neuroleptic: [3H]-YM-09151-2.

23

1 reference

10.1016/0024-3205(91)90261-9

https://api.crossref.org/works/10.1016/0024-3205(91)90261-9

4 December 2022

[125]I-spectramide: a novel benzamide displaying potent and selective effects at the D2 dopamine receptor.

24

1 reference

10.1016/0024-3205(91)90261-9

https://api.crossref.org/works/10.1016/0024-3205(91)90261-9

4 December 2022

Potential antipsychotic agents. 7. Synthesis and antidopaminergic properties of the atypical highly potent (S)-5-bromo-2,3-dimethoxy-N-[(1-ethyl-2-pyrrolidinyl)methyl]benzamide and related compounds. A comparative study.

29

1 reference

10.1016/0024-3205(91)90261-9

https://api.crossref.org/works/10.1016/0024-3205(91)90261-9

4 December 2022

LIGAND: A versatile computerized approach for characterization of ligand-binding systems

35

1 reference

10.1016/0024-3205(91)90261-9

https://api.crossref.org/works/10.1016/0024-3205(91)90261-9

4 December 2022

Characterization of the binding of 3H-SCH 23390, a selective D-1 receptor antagonist ligand, in rat striatum

36

1 reference

10.1016/0024-3205(91)90261-9

https://api.crossref.org/works/10.1016/0024-3205(91)90261-9

4 December 2022

Regulation of agonist and antagonist binding to striatal D-1 dopamine receptors: studies using the selective D-1 antagonist [3H]SK&F R-83566.

37

1 reference

10.1016/0024-3205(91)90261-9

https://api.crossref.org/works/10.1016/0024-3205(91)90261-9

4 December 2022

Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics

38

1 reference

10.1016/0024-3205(91)90261-9

https://api.crossref.org/works/10.1016/0024-3205(91)90261-9

4 December 2022

Effects of remoxipride and some related new substituted salicylamides on rat brain receptors.

41

1 reference

10.1016/0024-3205(91)90261-9

https://api.crossref.org/works/10.1016/0024-3205(91)90261-9

4 December 2022

Stereoselective binding of 11C-raclopride in living human brain--a search for extrastriatal central D2-dopamine receptors by PET.

42

1 reference

10.1016/0024-3205(91)90261-9

https://api.crossref.org/works/10.1016/0024-3205(91)90261-9

4 December 2022

Distribution of dopaminergic receptors in the primate cerebral cortex: quantitative autoradiographic analysis using [3H]raclopride, [3H]spiperone and [3H]SCH23390.

43

1 reference

10.1016/0024-3205(91)90261-9

https://api.crossref.org/works/10.1016/0024-3205(91)90261-9

4 December 2022

Synthesis and characterization of iodobenzamide analogues: potential D-2 dopamine receptor imaging agents

44

1 reference

10.1016/0024-3205(91)90261-9

https://api.crossref.org/works/10.1016/0024-3205(91)90261-9

4 December 2022

NCQ 298, a new selective iodinated salicylamide ligand for the labelling of dopamine D2 receptors

45

1 reference

10.1016/0024-3205(91)90261-9

https://api.crossref.org/works/10.1016/0024-3205(91)90261-9

4 December 2022

Identifiers

10.1016/0024-3205(91)90261-9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1830917%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1830917%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q67901608&oldid=1784553453"